Episode # 155 • 05 Mar 2024
Managing Biochemical Recurrence After Prostatectomy
In this episode of BackTable Urology, Dr. James Eastham, chief of urology at Memorial Sloan Kettering Cancer Center, discusses evolving approaches and treatments in prostate cancer.
This podcast is supported by
Timestamps
00:00 - Introduction
06:24 - Treatment Strategies and Patient Preferences
11:30 - Exploring the Role of Imaging in Prostate Cancer Treatment
18:29 - Dealing with Persistently Detectable PSA and Pre-op Staging
27:48 - Understanding Prostate Cancer Recurrence
36:08 - The Role of PSA Doubling Time in Treatment Decisions
43:34 - The Future of Personalized Medicine and Genomic Classifiers in Prostate Cancer
52:42 - The Importance of Patient Education and Preparation
Resources
You may also like
More about this episode
First, he discusses topics such as patient preparation, pre-treatment discussions, and individualized treatment options based on the patient's risk levels. Dr. Eastham also summarizes crucial advancements in testing and imaging prostate cancers, including the use of genetic and biochemical markers, like PSA levels. Additionally, he emphasizes how advances in radiation therapy have improved treatment outcomes and patient experiences. Finally, Dr. Eastham emphasizes the need for consistent monitoring and communication with patients during and post-treatment.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.